Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CZR | CAESARS ENTERTAINMENT INC | $5.63B | $27.06 | $44.23 | 63.46% | Strong Buy | 13 | 2.22% | N/A | 8.85% | 1.11% | |||
| SPB | SPECTRUM BRANDS HOLDINGS INC | $1.66B | $63.10 | $88.25 | 39.86% | Strong Buy | 4 | -3.45% | 3.43% | 5.41% | 3.04% | |||
| OTLY | OATLY GROUP AB | $303.47M | $10.14 | $22.67 | 123.54% | Strong Buy | 3 | 4.12% | N/A | -114.35% | -14.89% | |||
| HUMA | HUMACYTE INC | $224.92M | $1.45 | $19.00 | 1,210.34% | Strong Buy | 3 | N/A | N/A | -23.56% | 9.00% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $352.60M | $5.16 | $27.67 | 436.18% | Strong Buy | 3 | N/A | N/A | -51.80% | -46.97% | |||
| PASG | PASSAGE BIO INC | $20.26M | $0.33 | $7.67 | 2,251.84% | Strong Buy | 3 | N/A | N/A | -41.59% | -24.88% | |||
| LENZ | LENZ THERAPEUTICS INC | $785.39M | $28.52 | $42.67 | 49.63% | Strong Buy | 3 | N/A | N/A | 16.87% | 15.99% | |||
| IAC | IAC INC | $2.91B | $34.94 | $61.08 | 74.81% | Strong Buy | 13 | -0.84% | N/A | 3.67% | 2.14% | |||
| VERA | VERA THERAPEUTICS INC | $1.49B | $23.37 | $57.80 | 147.33% | Strong Buy | 5 | N/A | N/A | -1.40% | -1.23% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.